IOL Chemicals and Pharmaceuticals Limited — Important, 27-12-2024: Updates

The Board of Directors has addressed the recent delays in complying with SEBI regulations concerning the appointment of a Woman Independent Director and the composition of the Nomination and Remuneration Committee. The Board acknowledged that these delays were inadvertent, stemming from the need to identify a qualified candidate with specific skills and expertise. Following this process, Ms. Rajni Jha was appointed to the position on October 28, 2024. The Company has also confirmed the timely payment of fines imposed by both the BSE and NSE. The Board stressed the necessity of adhering to compliance timelines going forward, reinforcing a commitment to governance standards.